Location History:
- Le Mans, FR (2003 - 2007)
- Rouillon, FR (2006 - 2010)
Company Filing History:
3 out of 6 
1 out of 2 
1 out of 4 Years Active: 2003-2010
Title: Innovations of Julie Blanchard in Chemotherapy
Introduction
Julie Blanchard is a notable inventor based in Rouillon, France. She has made significant contributions to the field of chemotherapy through her innovative work on cephalotaxane derivatives. With a total of five patents to her name, her research focuses on improving the efficacy and purity of alkaloids used in cancer treatment.
Latest Patents
One of her latest patents involves a new general process for the asymmetric hemisynthesis of harringtonines and their analogs. This process includes the direct esterification of a natural cephalotaxine with an acylating compound. The resulting compounds are designed to have a total content of impurities lower than 1%, ensuring a high level of purity. The patent also covers natural, synthetic, or semi-synthetic forms of harringtonines, including their tautomeric forms and salts, with a chromatographic assay exhibiting a content higher than 97.5%.
Career Highlights
Throughout her career, Julie has worked with several prominent companies in the pharmaceutical industry. Notably, she has been associated with Stragen Pharma and Oncopharm Corporation. Her work in these organizations has allowed her to advance her research and contribute to the development of effective chemotherapy treatments.
Collaborations
Julie has collaborated with esteemed colleagues such as Jean-Pierre Robin and Ludovic Chauviat. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.
Conclusion
Julie Blanchard's contributions to the field of chemotherapy through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to impact the development of effective cancer treatments.